A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101R. Michael Baldwin, Deanna L. Kroetz, Kouros Owzar et al.|Clinical Cancer Research|2012Cited by 206
A Genome-Wide Association Study of Overall Survival in Pancreatic Cancer Patients Treated with Gemcitabine in CALGB 80303Federico Innocenti, Mark J. Ratain, Herbert I. Hurwitz et al.|Clinical Cancer Research|2011Cited by 110
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a <i>VAC14</i> Polymorphism that Increases Risk of Docetaxel-Induced NeuropathyDaniel L. Hertz, Howard L. McLeod, Kouros Owzar et al.|Clinical Cancer Research|2016Cited by 57
Genomewide Meta‐Analysis Validates a Role for <i>S1PR1</i> in Microtubule Targeting Agent‐Induced Sensory Peripheral NeuropathyKatherina C. Chua, Deanna L. Kroetz, Chenling Xiong et al.|Clinical Pharmacology & Therapeutics|2020Cited by 47
Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration‐resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance)Jai N. Patel, Howard L. McLeod, Chen Jiang et al.|Cancer|2014Cited by 35